This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
Tag: DMC

DMC in ALS
During the course of their disease, around 90% of patients with ALS develop speech or swallowing difficulties – so-called bulbar symptoms. Around a third of all patients already show bulbar symptoms at the onset of ALS. Dextromethorphan/quinidine (DMC) has established itself as an off-label treatment option to alleviate these symptoms in ALS. In a patient…

